We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+3.24%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$33.7B
AUM Growth
+$1.52B
(+4.7%)
Cap. Flow
+$861M
Cap. Flow
% of AUM
2.55%
Top 10 Holdings %
Top 10 Hldgs %
14.52%
Holding
3,141
New
144
Increased
1,491
Reduced
1,301
Closed
155
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
S&P Global
SPGI
|
+$43.1M |
| 2 |
ExxonMobil
XOM
|
+$33.4M |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
+$27.9M |
| 4 |
Meta Platforms (Facebook)
META
|
+$26.7M |
| 5 |
Johnson & Johnson
JNJ
|
+$25.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TWC
TIME WARNER CABLE INC NEW COM STK
TWC
|
+$86.8M |
| 2 |
MHFI
MCGRAW-HILL FINANCIAL INC COM
MHFI
|
+$42.6M |
| 3 |
BXLT
BAXALTA INC COM STK (DE)
BXLT
|
+$30.6M |
| 4 |
SNDK
SANDISK CORP
SNDK
|
+$22.1M |
| 5 |
JAH
JARDEN CORPORATION
JAH
|
+$21.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 14.29% |
| 2 | Financials | 14.18% |
| 3 | Technology | 13.8% |
| 4 | Industrials | 10.4% |
| 5 | Consumer Discretionary | 9.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2751
Destination XL Group
DXLG
$31.2M
| $195K | ﹤0.01% |
42,762
-11,114
| -21% | -$55.2K |
|
2752
Rapid7
RPD
$645M
| $195K | ﹤0.01% |
+15,532
| New | +$197K |
|
2753
Build-A-Bear
BBW
$425M
| $194K | ﹤0.01% |
14,487
-5,612
| -28% | -$75K |
|
|
CNCE
2754
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
| $194K | ﹤0.01% |
17,248
+2,414
| +16% | +$30.7K |
|
|
GBT
2755
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $194K | ﹤0.01% |
+11,671
| New | +$235K |
|
|
QADA
2756
DELISTED
QAD Inc.
QADA
| $194K | ﹤0.01% |
10,083
-2,737
| -21% | -$54K |
|
2757
Freshpet
FRPT
$2.93B
| $193K | ﹤0.01% |
20,700
+860
| +4% | +$7.42K |
|
2758
Sportsman's Warehouse
SPWH
$44.5M
| $193K | ﹤0.01% |
23,898
+2,013
| +9% | +$20.1K |
|
2759
Anavex Life Sciences
AVXL
$255M
| $192K | ﹤0.01% |
+31,376
| New | +$152K |
|
2760
Lifetime Brands
LCUT
$191M
| $192K | ﹤0.01% |
13,128
-3,021
| -19% | -$47K |
|
|
PRTK
2761
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
| $192K | ﹤0.01% |
13,792
+1,510
| +12% | +$22.2K |
|
2762
Alto Ingredients
ALTO
$369M
| $191K | ﹤0.01% |
35,095
-10,455
| -23% | -$51.9K |
|
|
CUTR
2763
DELISTED
Cutera, Inc.
CUTR
| $191K | ﹤0.01% |
17,006
+1,235
| +8% | +$13.5K |
|
2764
Green Brick Partners
GRBK
$3.04B
| $190K | ﹤0.01% |
26,108
-4,870
| -16% | -$35.5K |
|
2765
RadNet
RDNT
$5.02B
| $189K | ﹤0.01% |
35,350
+1,685
| +5% | +$8.71K |
|
|
XONE
2766
DELISTED
The ExOne Company
XONE
| $189K | ﹤0.01% |
17,849
+1,645
| +10% | +$18.6K |
|
|
COB
2767
DELISTED
CommunityOne Bancorp
COB
| $189K | ﹤0.01% |
14,949
-3,725
| -20% | -$49.1K |
|
|
RELY
2768
DELISTED
Real Industry, Inc.
RELY
| $189K | ﹤0.01% |
24,318
-2,897
| -11% | -$23.5K |
|
2769
Immunic
IMUX
$190M
| $188K | ﹤0.01% |
76
+27
| +55% | +$88.7K |
|
2770
Kopin
KOPN
$652M
| $188K | ﹤0.01% |
84,655
-32,313
| -28% | -$62.4K |
|
2771
MediciNova
MNOV
$65.5M
| $188K | ﹤0.01% |
+24,887
| New | +$180K |
|
2772
PennyMac Financial
PFSI
$3.92B
| $188K | ﹤0.01% |
15,042
-3,274
| -18% | -$42.5K |
|
|
GNMX
2773
DELISTED
Aevi Genomic Medicine Inc
GNMX
| $187K | ﹤0.01% |
33,718
+15,333
| +83% | +$80.5K |
|
|
MR
2774
DELISTED
Montage Resources Corporation Common Stock
MR
| $186K | ﹤0.01% |
3,717
-951
| -20% | -$39.1K |
|
|
CTRL
2775
DELISTED
Control4 Corporation
CTRL
| $186K | ﹤0.01% |
22,769
-6,905
| -23% | -$53.4K |
|
Similar funds
VAM
RhumbLine Advisers's Q2 2016 Portfolio in Review
As of Q2 2016, RhumbLine Advisers held 3,141 positions worth $33.7B, up 4.7% from $32.2B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
RhumbLine Advisers's Q2 2016 filing shows 144 new, 1,491 increased, 1,301 reduced and 155 closed positions. Its largest new stake was S&P Global: 401,386 shares worth $43.1M. The largest sale was TIME WARNER CABLE INC NEW COM STK, an estimated $86.8M.
By sector, the portfolio is most concentrated in Healthcare at 14% of assets, up from 14% a quarter earlier, followed by Financials and Technology.
- RhumbLine Advisers's largest Q2 2016 buy was S&P Global: 401,386 shares worth $43.1M.
- RhumbLine Advisers added most to ExxonMobil in Q2 2016, an estimated $33.4M increase.
- RhumbLine Advisers's biggest Q2 2016 reduction was Coca-Cola Europacific Partners, cutting an estimated $16.1M.
- RhumbLine Advisers fully exited TIME WARNER CABLE INC NEW COM STK in Q2 2016, selling an estimated $86.8M.
- RhumbLine Advisers's ten largest holdings make up 15% of its $33.7B portfolio in Q2 2016.
- RhumbLine Advisers opened 144 new positions and closed 155 in Q2 2016.
- RhumbLine Advisers's portfolio value rose 4.7% quarter-over-quarter to $33.7B.
Based on RhumbLine Advisers's 13F filing for Q2 2016, filed 11 Aug 2016.